Computed Tomography Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Technology (High-end slice, Mid end slice, Low-end slice, Cone beam), By Application (Oncology, Neurology, Cardiology, Musculoskeletal, Others), By End user (Hospitals & Clinics, Diagnostics imaging center, Others), By Region and Competition, 2020-2030F

Market Overview

The Global Computed Tomography Market, valued at USD 5.25 Billion in 2024, is projected to experience a CAGR of 5.95% to reach USD 7.43 Billion by 2030. Computed Tomography (CT) employs X-rays and computer processing to generate detailed cross-sectional images of the body, enabling precise visualization of bones, soft tissues, and vasculature for diagnostic purposes. The market for CT systems is significantly driven by an aging global demographic and the increasing incidence of chronic diseases, such as cardiovascular conditions and cancer, necessitating advanced diagnostic imaging. According to AdvaMed's 2023 Pulse of the Industry report, the broader medical technology sector, encompassing CT, achieved total revenue of US$573 billion in 2022, underscoring the industry's significant scale.

Further impetus for market growth stems from ongoing technological advancements that enhance image resolution and reduce radiation exposure, alongside expanding healthcare infrastructure in emerging economies. Despite this positive trajectory, a significant challenge impeding market expansion is the substantial initial capital outlay required for acquiring and installing CT scanners, coupled with considerable ongoing maintenance expenses. This financial burden for healthcare providers can constrain broader adoption and limit accessibility in certain regions.

Key Market Drivers

Two significant drivers influencing the global Computed Tomography market are ongoing technological advancements in CT systems and the rising global prevalence of chronic diseases. Continuous innovation in CT technology, exemplified by developments such as photon-counting CT, is enhancing diagnostic capabilities through improved image resolution and reduced radiation exposure, thereby expanding the clinical utility of these systems. According to Siemens Healthineers, in December 2024, the company committed an investment of €80 million ($86 million) to expand its photon-counting detector production in Forchheim, Germany, reflecting the strategic importance and anticipated growth of advanced CT solutions. Simultaneously, the increasing burden of chronic conditions globally necessitates advanced diagnostic imaging for early and accurate disease detection and monitoring. This includes a wide range of diseases such as cancer, cardiovascular disorders, and neurological conditions. According to the World Health Organization and the International Agency for Research on Cancer, in February 2024, Global cancer burden growing, amidst mounting need for services, estimated 20 million new cancer cases occurred in 2022, underscoring a substantial demand for precise diagnostic tools like CT.

The confluence of these factors fuels market expansion by improving patient outcomes and streamlining healthcare workflows. The broader medical technology sector, including CT systems, continues to demonstrate robust financial performance. For instance, according to GE HealthCare's fourth quarter and full year 2024 financial results, in February 2025, the company reported total revenues of $19.7 billion for the full year 2024, driven by sustained demand for its products and services, notably within Advanced Visualization Solutions. This sustained investment and increasing disease incidence highlight the foundational elements propelling the Computed Tomography market forward.

Download Free Sample Report

Key Market Challenges

The substantial initial capital outlay required for acquiring and installing Computed Tomography scanners, coupled with considerable ongoing maintenance expenses, represents a significant impediment to the growth of the global market. These financial burdens directly constrain broader adoption of CT systems by healthcare providers, particularly those operating with limited capital budgets. The high cost of new CT equipment, alongside recurring service contracts and operational costs, creates a substantial barrier to entry and limits the replacement cycles for existing equipment. According to the Radiological Society of North America's (RSNA) 2023 Annual Report, the organization approved over $4.7 million in grant funding for 83 individuals across 44 institutions, highlighting the significant financial commitments within the broader radiology field. This level of investment for research and development activities demonstrates the substantial financial environment healthcare institutions navigate. Consequently, the considerable expense for CT scanners further restricts the expansion of advanced diagnostic imaging capabilities, particularly in developing regions and smaller healthcare facilities, thereby directly impeding market growth by limiting accessibility and widespread implementation.

Key Market Trends

Artificial intelligence integration is a prominent trend transforming the Computed Tomography market by improving diagnostic accuracy and automating workflows. This advancement allows for faster image analysis, reduced burden on radiologists, and enhanced clinical decision-making. According to the Radiological Society of North America (RSNA), in December 2024, nearly 80% of the approximately 1,000 clinical AI algorithms cleared by the U. S. Food and Drug Administration were for medical imaging. The increasing sophistication of AI algorithms enables precise detection of subtle anomalies, contributing to earlier and more accurate diagnoses. For example, in December 2023, Canon Medical Systems introduced new AI-based CT systems, the Aquilion ONE / INSIGHT Edition and Aquilion Serve SP, incorporating advanced AI algorithms to both enhance image quality and streamline scanner operations. This trend is crucial for optimizing healthcare delivery and addressing the growing demand for efficient diagnostic services.

The expansion of portable and point-of-care CT systems represents another significant trend, driven by the need for greater accessibility and efficiency in diagnostic imaging. These compact systems enable imaging in various clinical settings beyond traditional radiology departments, such as emergency rooms, intensive care units, and even remote locations, bringing diagnostics closer to the patient. This trend is particularly relevant given workforce challenges in the sector; the Radiological Society of North America (RSNA) reported that approximately 5,500 radiologists exited the workforce by Q4 2023, an 11% decrease from Q4 2022, underscoring the increasing demands on existing personnel. Such systems help alleviate these pressures by offering flexible deployment and quicker diagnostic turnaround. In February 2025, Canon Medical unveiled an expansion of its battery-powered imaging systems and introduced modular diagnostic units at ECR 2025, recognizing the growing requirement for mobile and remote diagnostic capabilities.

Segmental Insights

The oncology segment is experiencing the fastest growth within the Global Computed Tomography Market, primarily driven by the increasing global prevalence of various cancer types, necessitating advanced diagnostic and monitoring tools. Computed tomography is indispensable for the early and accurate detection of tumors, precise disease staging, and comprehensive planning of radiation therapy. The growing demand to evaluate treatment effectiveness and monitor disease progression critically relies on the detailed imaging capabilities that CT systems provide, enabling precise visualization of tumor characteristics. Furthermore, continuous technological advancements in CT, enhancing image quality and diagnostic precision, solidify its integral role in modern oncology care.

Regional Insights

North America holds a leading position in the Global Computed Tomography Market, primarily driven by its robust healthcare infrastructure and substantial healthcare expenditure. The region demonstrates a high adoption rate of advanced medical imaging technologies, a trend supported by continuous technological innovation. A significant prevalence of chronic diseases and an aging population further fuels the demand for advanced diagnostic imaging procedures. Additionally, favorable reimbursement policies and a strong regulatory environment, exemplified by the oversight of the U. S. Food and Drug Administration (FDA), encourage investment and rapid diffusion of CT technology. The presence of major market players also contributes to North America's sustained market dominance.

Recent Developments

• In August 2025, researchers at the University of California, Davis, advanced a breakthrough medical imaging technique combining Positron Emission Tomography (PET) and dual-energy Computed Tomography (CT). This innovative method, referred to as PET-enabled Dual-Energy CT, aims to significantly enhance the detection and understanding of various diseases, including cancer and bone and heart conditions. Funded by a $2.5 million federal grant, the research utilizes a total body PET scanner, a platform developed by UC Davis Health and United Imaging Healthcare, to validate the technique. This development allows for improved visualization of tissue composition in a single scan, potentially transforming diagnostic capabilities without requiring new hardware on existing PET/CT systems.

• In December 2024, Siemens Healthineers expanded its photon-counting computed tomography (PCCT) portfolio with the introduction of the new Naeotom Alpha class. This expansion included a new dual-source scanner, the Naeotom Alpha.Pro, and the world's first single-source PCCT system, the Naeotom Alpha.Prime. The company's flagship Naeotom Alpha was also refreshed as the Alpha.Peak. These systems aim to offer high image quality at reduced radiation doses, leveraging spectral imaging capabilities and artificial intelligence for enhanced diagnostic precision. The initiative underscores Siemens Healthineers' strategy to advance PCCT technology across a broader range of clinical applications in the computed tomography market.

• In June 2024, FUJIFILM Healthcare Americas Corporation announced the U.S. Food and Drug Administration (FDA) clearance for its new compact, 128-slice computed tomography system, the FCT iStream. This system incorporates four proprietary Fujifilm technologies, including HiMAR Plus and SynergyDrive, designed to improve image sharpness and significantly reduce patient radiation dose. The FCT iStream also leverages AI automation to streamline the imaging workflow, assisting with patient positioning, parameter mapping, and image archiving. This launch reinforces the company's commitment to delivering diagnostic solutions that enhance clinical outcomes and operational efficiency in the global computed tomography market.

• In March 2024, Philips launched its new AI-enabled CT 5300 system, targeting the growing cardiac computed tomography angiography market. The system integrates advanced artificial intelligence features to enhance image quality and streamline clinical workflows. This innovation enables more precise and reliable imaging for complex cardiac cases, simultaneously improving diagnostic confidence and departmental efficiency. The CT 5300 system also incorporates a new detector designed to optimize AI image reconstruction algorithms, and offers virtual tools for real-time collaboration and support, aiming to address challenges such as increased patient caseloads and staff shortages within radiology departments.

Key Market Players

• Koninklijke Philips N.V.
• GE HealthCare Technologies, Inc.
• Siemens Healthineers AG
• CANON MEDICAL SYSTEMS CORPORATION
• FUJIFILM Corporation
• NeuroLogica Corp
• Neusoft Corporation
• Shenzhen Anke High-Tech Co

Report Scope:

In this report, the Global Computed Tomography Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

• Computed Tomography Market, By Technology:

o   High-end slice

o   Mid end slice

o   Low-end slice

o   Cone beam

• Computed Tomography Market, By Application:

o   Oncology

o   Neurology

o   Cardiology

o   Musculoskeletal

o   Others

• Computed Tomography Market, By End User:

o   Hospitals & Clinics

o   Diagnostics imaging Centre

o   Others

• Computed Tomography Market, By Region:

o   North America

§  United States

§  Canada

§  Mexico

o   Europe

§  France

§  United Kingdom

§  Italy

§  Germany

§  Spain

o   Asia Pacific

§  China

§  India

§  Japan

§  Australia

§  South Korea

o   South America

§  Brazil

§  Argentina

§  Colombia

o   Middle East & Africa

§  South Africa

§  Saudi Arabia

§  UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies presents in the Global Computed Tomography Market.

Available Customizations:

Global Computed Tomography Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Global Computed Tomography Market is an upcoming report to be released soon. If you wish an early delivery of this report or want to confirm the date of release, please contact us at [email protected]